搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規(guī)格
Recombinant Actinobacillus pleuropneumoniae serotype 7 Protein MraZ (mraZ) CSB-YP459198AXI
CSB-EP459198AXI
CSB-BP459198AXI
CSB-MP459198AXI
CSB-EP459198AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 D-alanine--D-alanine ligase (ddl) CSB-YP459199AXI
CSB-EP459199AXI
CSB-BP459199AXI
CSB-MP459199AXI
CSB-EP459199AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 Ribonuclease PH (rph) CSB-YP459200AXI
CSB-EP459200AXI
CSB-BP459200AXI
CSB-MP459200AXI
CSB-EP459200AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 Ribonuclease HII (rnhB) CSB-YP459201AXI
CSB-EP459201AXI
CSB-BP459201AXI
CSB-MP459201AXI
CSB-EP459201AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 3-dehydroquinate synthase (aroB) CSB-YP459202AXI
CSB-EP459202AXI
CSB-BP459202AXI
CSB-MP459202AXI
CSB-EP459202AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 1,4-alpha-glucan branching enzyme GlgB (glgB), partial CSB-YP459203AXI
CSB-EP459203AXI
CSB-BP459203AXI
CSB-MP459203AXI
CSB-EP459203AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 Autonomous glycyl radical cofactor (grcA) CSB-YP459204AXI
CSB-EP459204AXI
CSB-BP459204AXI
CSB-MP459204AXI
CSB-EP459204AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP459205AXI
CSB-EP459205AXI
CSB-BP459205AXI
CSB-MP459205AXI
CSB-EP459205AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 Chromosome partition protein MukB (mukB), partial CSB-YP459206AXI
CSB-EP459206AXI
CSB-BP459206AXI
CSB-MP459206AXI
CSB-EP459206AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 Ribosome maturation factor RimP (rimP) CSB-YP459207AXI
CSB-EP459207AXI
CSB-BP459207AXI
CSB-MP459207AXI
CSB-EP459207AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 Alanine--tRNA ligase (alaS), partial CSB-YP459208AXI
CSB-EP459208AXI
CSB-BP459208AXI
CSB-MP459208AXI
CSB-EP459208AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP459209AXI
CSB-EP459209AXI
CSB-BP459209AXI
CSB-MP459209AXI
CSB-EP459209AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 Peptidase E (pepE) CSB-YP459210AXI
CSB-EP459210AXI
CSB-BP459210AXI
CSB-MP459210AXI
CSB-EP459210AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 30S ribosomal protein S15 (rpsO) CSB-YP459211AXI
CSB-EP459211AXI
CSB-BP459211AXI
CSB-MP459211AXI
CSB-EP459211AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 UPF0234 protein APP7_1280 (APP7_1280) CSB-YP459212AXI
CSB-EP459212AXI
CSB-BP459212AXI
CSB-MP459212AXI
CSB-EP459212AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 Adenylate kinase (adk) CSB-YP459213AXI
CSB-EP459213AXI
CSB-BP459213AXI
CSB-MP459213AXI
CSB-EP459213AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 Iron--sulfur cluster insertion protein ErpA (erpA) CSB-YP459214AXI
CSB-EP459214AXI
CSB-BP459214AXI
CSB-MP459214AXI
CSB-EP459214AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 30S ribosomal protein S12 (rpsL) CSB-YP459215AXI
CSB-EP459215AXI
CSB-BP459215AXI
CSB-MP459215AXI
CSB-EP459215AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha (accA) CSB-YP459216AXI
CSB-EP459216AXI
CSB-BP459216AXI
CSB-MP459216AXI
CSB-EP459216AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Actinobacillus pleuropneumoniae serotype 7 Octanoyltransferase (lipB) CSB-YP459217AXI
CSB-EP459217AXI
CSB-BP459217AXI
CSB-MP459217AXI
CSB-EP459217AXI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業(yè)產品。重組蛋白的技術資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>